TCNNF
Price
$5.20
Change
-$0.00 (-0.00%)
Updated
Nov 18 closing price
Capitalization
987.62M
99 days until earnings call
Intraday BUY SELL Signals
TSNDF
Price
$0.39
Change
-$0.04 (-9.30%)
Updated
Nov 18 closing price
Capitalization
119.57M
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TCNNF vs TSNDF

Header iconTCNNF vs TSNDF Comparison
Open Charts TCNNF vs TSNDFBanner chart's image
Trulieve Cannabis
Price$5.20
Change-$0.00 (-0.00%)
Volume$284.08K
Capitalization987.62M
TerrAscend
Price$0.39
Change-$0.04 (-9.30%)
Volume$460.21K
Capitalization119.57M
TCNNF vs TSNDF Comparison Chart in %
TCNNF
Daily Signal:
Gain/Loss:
TSNDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TCNNF vs. TSNDF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCNNF is a Hold and TSNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (TCNNF: $5.20 vs. TSNDF: $0.39)
Brand notoriety: TCNNF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TCNNF: 76% vs. TSNDF: 93%
Market capitalization -- TCNNF: $903.19M vs. TSNDF: $115.73M
TCNNF [@Pharmaceuticals: Generic] is valued at $903.19M. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $115.73M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCNNF’s FA Score shows that 1 FA rating(s) are green whileTSNDF’s FA Score has 0 green FA rating(s).

  • TCNNF’s FA Score: 1 green, 4 red.
  • TSNDF’s FA Score: 0 green, 5 red.
According to our system of comparison, TCNNF is a better buy in the long-term than TSNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCNNF’s TA Score shows that 4 TA indicator(s) are bullish while TSNDF’s TA Score has 4 bullish TA indicator(s).

  • TCNNF’s TA Score: 4 bullish, 5 bearish.
  • TSNDF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TCNNF is a better buy in the short-term than TSNDF.

Price Growth

TCNNF (@Pharmaceuticals: Generic) experienced а -25.07% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was -46.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Reported Earning Dates

TCNNF is expected to report earnings on Feb 26, 2026.

TSNDF is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCNNF($988M) has a higher market cap than TSNDF($120M). TCNNF YTD gains are higher at: 0.318 vs. TSNDF (-39.431). TCNNF has higher annual earnings (EBITDA): 280M vs. TSNDF (11.3M). TCNNF has more cash in the bank: 393M vs. TSNDF (27.7M). TSNDF has less debt than TCNNF: TSNDF (242M) vs TCNNF (824M). TCNNF has higher revenues than TSNDF: TCNNF (1.19B) vs TSNDF (300M).
TCNNFTSNDFTCNNF / TSNDF
Capitalization988M120M823%
EBITDA280M11.3M2,478%
Gain YTD0.318-39.431-1%
P/E RatioN/A9.84-
Revenue1.19B300M395%
Total Cash393M27.7M1,419%
Total Debt824M242M340%
FUNDAMENTALS RATINGS
TCNNF vs TSNDF: Fundamental Ratings
TCNNF
TSNDF
OUTLOOK RATING
1..100
5974
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9297
PRICE GROWTH RATING
1..100
6566
P/E GROWTH RATING
1..100
1299
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSNDF's Valuation (53) in the null industry is in the same range as TCNNF (81). This means that TSNDF’s stock grew similarly to TCNNF’s over the last 12 months.

TSNDF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that TSNDF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's SMR Rating (92) in the null industry is in the same range as TSNDF (97). This means that TCNNF’s stock grew similarly to TSNDF’s over the last 12 months.

TCNNF's Price Growth Rating (65) in the null industry is in the same range as TSNDF (66). This means that TCNNF’s stock grew similarly to TSNDF’s over the last 12 months.

TCNNF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for TSNDF (99). This means that TCNNF’s stock grew significantly faster than TSNDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TCNNFTSNDF
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TCNNF
Daily Signal:
Gain/Loss:
TSNDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAOIX30.41N/A
N/A
NAA Opportunity Institutional
JGECX13.05N/A
N/A
JHancock Global Equity C
TSMGX16.71N/A
N/A
Touchstone Sands Cptl Emerg Mkts Gr A
JVAPX38.04N/A
N/A
JPMorgan Value Advantage R3
WRAIX14.13-0.01
-0.07%
Wilmington Global Alpha Equities I

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
N/A
GTBIF - TCNNF
83%
Closely correlated
-2.69%
CURLF - TCNNF
80%
Closely correlated
-2.45%
TSNDF - TCNNF
76%
Closely correlated
-9.29%
CRLBF - TCNNF
75%
Closely correlated
-10.26%
JUSHF - TCNNF
73%
Closely correlated
-2.63%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
-9.29%
GTBIF - TSNDF
78%
Closely correlated
-2.69%
CRLBF - TSNDF
76%
Closely correlated
-10.26%
TCNNF - TSNDF
76%
Closely correlated
N/A
CURLF - TSNDF
74%
Closely correlated
-2.45%
JUSHF - TSNDF
72%
Closely correlated
-2.63%
More